Targeting proteases: successes, failures and future prospects (Q34563752)

3 August 2017

1 reference

title

Targeting proteases: successes, failures and future prospects (English)

1 reference

3 August 2017

Boris Turk

1

0 references

publication date

1 September 2006

1 reference

Nature Reviews Drug Discovery

3 August 2017

1 reference

3 August 2017

5

1 reference

3 August 2017

9

1 reference

3 August 2017

785-799

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2092

3 August 2017

0 references

cites work

Human and mouse proteases: a comparative genomic approach

1 reference

MEROPS: the peptidase database.

31 March 2020

1 reference

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

31 March 2020

1 reference

AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

31 March 2020

1 reference

Protease degradomics: a new challenge for proteomics

31 March 2020

1 reference

A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes

31 March 2020

1 reference

ADAMs: key components in EGFR signalling and development

31 March 2020

1 reference

Furin at the cutting edge: from protein traffic to embryogenesis and disease

31 March 2020

1 reference

Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides

31 March 2020

1 reference

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

31 March 2020

1 reference

The coagulation cascade: initiation, maintenance, and regulation

31 March 2020

1 reference

Unraveling the role of proteases in cancer

31 March 2020

1 reference

Reprieval from execution: the molecular basis of caspase inhibition

31 March 2020

1 reference

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

31 March 2020

1 reference

Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection

31 March 2020

1 reference

A new oral anticoagulant: the 50-year challenge

31 March 2020

1 reference

Protease inhibitors in the clinic.

31 March 2020

1 reference

Current anticoagulant therapy--unmet clinical needs

31 March 2020

1 reference

Drugs targeting the renin-angiotensin-aldosterone system

31 March 2020

1 reference

Ace revisited: a new target for structure-based drug design.

31 March 2020

1 reference

Crystal structure of the human angiotensin-converting enzyme-lisinopril complex

31 March 2020

1 reference

Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction

31 March 2020

1 reference

Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors

31 March 2020

1 reference

Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase

31 March 2020

1 reference

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

31 March 2020

1 reference

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

31 March 2020

1 reference

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

31 March 2020

1 reference

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

31 March 2020

1 reference

Fluorescent probes for proteolysis: tools for drug discovery

31 March 2020

1 reference

Enzyme activity--it's all about image

31 March 2020

1 reference

Dynamic imaging of protease activity with fluorescently quenched activity-based probes.

31 March 2020

1 reference

A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR

31 March 2020

1 reference

The preparation and function of the hypertensin-converting enzyme

31 March 2020

1 reference

Substrate phage: selection of protease substrates by monovalent phage display

31 March 2020

1 reference

Definition and redesign of the extended substrate specificity of granzyme B.

31 March 2020

1 reference

Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries

31 March 2020

1 reference

Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery

31 March 2020

1 reference

A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis

31 March 2020

1 reference

Determination of protease cleavage site motifs using mixture-based oriented peptide libraries

31 March 2020

1 reference

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

31 March 2020

1 reference

Distinct roles for cysteine cathepsin genes in multistage tumorigenesis

31 March 2020

1 reference

Matrix metalloproteinases as valid clinical targets

31 March 2020

1 reference

The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme

31 March 2020

1 reference

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

31 March 2020

1 reference

Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates

31 March 2020

1 reference

A proteomic approach for the discovery of protease substrates

31 March 2020

1 reference

Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis.

31 March 2020

1 reference

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

31 March 2020

1 reference

Apoptosis-based therapies

31 March 2020

1 reference

New insight into how tissue factor allosterically regulates factor VIIa

31 March 2020

1 reference

Identification of critical molecular interactions mediating heparin activation of antithrombin: implications for the design of improved heparin anticoagulants

31 March 2020

1 reference

Natural protein proteinase inhibitors and their interaction with proteinases

31 March 2020

1 reference

Structural basis of the endoproteinase-protein inhibitor interaction

31 March 2020

1 reference

Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators

31 March 2020

1 reference

Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.

31 March 2020

1 reference

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo

31 March 2020

1 reference

Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro

31 March 2020

1 reference

A specific mechanism of nonspecific inhibition

31 March 2020

1 reference

Antiviral drugs in current clinical use.

31 March 2020

1 reference

Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity

31 March 2020

1 reference

Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors

31 March 2020

1 reference

Identification of a Potent and Selective Noncovalent Cathepsin S Inhibitor

31 March 2020

1 reference

Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents

31 March 2020

1 reference

Searching for new allosteric sites in enzymes

31 March 2020

1 reference

Discovery of an allosteric site in the caspases

31 March 2020

1 reference

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity

31 March 2020

1 reference

Importance of the hinge region between alpha-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies

31 March 2020

1 reference

Therapeutic potential of renin inhibitors in the management of cardiovascular disorders

31 March 2020

1 reference

Dose-Dependent Effects of the Renin Inhibitor Zankiren HCl After a Single Oral Dose in Mildly Sodium-Depleted Normotensive Subjects

31 March 2020

1 reference

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

31 March 2020

1 reference

Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats

31 March 2020

1 reference

Blood pressure-independent effects in rats with human renin and angiotensinogen genes.

31 March 2020

1 reference

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

31 March 2020

1 reference

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

31 March 2020

1 reference

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

31 March 2020

1 reference

Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats

31 March 2020

1 reference

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

31 March 2020

1 reference

Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes

31 March 2020

1 reference

Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors

31 March 2020

1 reference

The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.

31 March 2020

1 reference

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

31 March 2020

1 reference

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

31 March 2020

1 reference

Chemokines: multiple levels of leukocyte migration control.

31 March 2020

1 reference

Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.

31 March 2020

1 reference

Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency

31 March 2020

1 reference

Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice

31 March 2020

1 reference

Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization

31 March 2020

1 reference

Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K

31 March 2020

1 reference

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone

31 March 2020

1 reference

Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate

31 March 2020

1 reference

Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.

31 March 2020

1 reference

Revised definition of substrate binding sites of papain-like cysteine proteases

31 March 2020

1 reference

Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity

31 March 2020

1 reference

6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents

31 March 2020

1 reference

Ketoheterocycle-based inhibitors of cathepsin K: a novel entry into the synthesis of peptidic ketoheterocycles

31 March 2020

1 reference

Antimetastatic activity of a novel mechanism-based gelatinase inhibitor

31 March 2020

1 reference

A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.

31 March 2020

1 reference

Potent mechanism-based inhibitors for matrix metalloproteinases

31 March 2020

1 reference

Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes

31 March 2020

1 reference

The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease

31 March 2020

1 reference

On the size of the active site in proteases. I. Papain

31 March 2020

1 reference

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

31 March 2020

1 reference

Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs

31 March 2020

1 reference

Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome

31 March 2020

1 reference

Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases

31 March 2020

1 reference

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

31 March 2020

1 reference

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

31 March 2020

1 reference

Mechanism of XIAP-mediated inhibition of caspase-9

31 March 2020

1 reference

X-linked IAP is a direct inhibitor of cell-death proteases

31 March 2020

1 reference

Lysosomal cysteine proteases: more than scavengers

31 March 2020

1 reference

Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD2092

1 reference

3 August 2017

1 reference

PubMed ID

16955069